GeoVax Labs GOVX
NASDAQ GOVX
$0.35 +0.01 (+1.82%)
At close: Sep 29, 2026 · 4:00 PM EDT

GeoVax Labs (GOVX) Operating Leases (2025 - 2026)

Updated

GeoVax Labs' Operating Leases came in at $169,568 for Q2 2026.

Analysis

GeoVax Labs (GOVX) Operating Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, GeoVax Labs' Operating Leases was $580,035.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 GeoVax Labs 1.60 Mn -12.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 169,568.00
Dec 31, 2025 580,035.00
API Access

GeoVax Labs Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=GOVX&period=max&api_key=YOUR_API_KEY